Abstract 518: Erk5 S496 Phosphorylation, But Not Erk5 Kinase Or Transcriptional Activity, Is Responsible For Promoting Macrophage Inflammation And Mitochondrial Dysfunction Via Upregulating Novel Site Of Nrf2 K518 Sumoylation
Sivareddy Kotla(University of Tennessee Health Science Center), Jun‐ichi Abe(The University of Texas MD Anderson Cancer Center), Rei Abe(Houston Methodist), Cielito C. Reyes‐Gibby(The University of Texas MD Anderson Cancer Center), Venkatasubrahman Samanthapudi, Anita Deswal(The University of Texas MD Anderson Cancer Center), Hannah Savage(The University of Texas MD Anderson Cancer Center), Dale J. Hamilton(Cornell University), Masaki Imanishi(Tokushima University Hospital), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Sai‐Ching J. Yeung(The University of Texas MD Anderson Cancer Center), Henry J. Pownall(Cornell University), Guangyu Wang(Tongji University), Kyung Ae Ko(The University of Texas MD Anderson Cancer Center), Keigi Fujiwara(Norwegian Womens Public Health Association), Aijun Zhang(Cornell University), Keri Schadler(The University of Texas MD Anderson Cancer Center), Shengyu Li(Houston Methodist), Nhat-Tu Le(The University of Texas MD Anderson Cancer Center)
Cited by 1
Related Papers
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
|The Lancet Diabetes & Endocrinology|2016|728
Neuropeptide S
|Neuron|2004|516
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2019|435
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure
|Journal of Cardiac Failure|2022|406